Phase IIb and III: Where and Why

Phase IIb and III, Where and When

Today’s clinical studies are burdened by cumbersome designs, are often ineffectively powered and target inappropriate endpoints. Cumbersome designs result in delays, failures and increased costs. An effective clinical study design, minimizing clinical study complexity while capturing key endpoints with the right tools, is essential for successful clinical development. Having fewer procedures without adversely impacting the study’s goals, can help your study design facilitate patient recruitment, reduce costly delays and collect necessary data to satisfy internal and external stakeholders.

 

Where you conduct your study can help or hinder your objectives. We can also help you decide on the best region to conduct your study based on

 

  • Quality
  • Time
  • Cost
  • Market

 

How does each region differ with respect to study cost, quality, complexity and timelines? How does local treatment practice influence your study design? The answers may be surprising and need to be known before selecting where to conduct your study.

 

  • Complexity
  • Patient Population
  • Logistics

 

 

2016 Armstrong Clinical Pty. Ltd.